---
figid: PMC11033211__PGPM-17-133-g0005
pmcid: PMC11033211
image_filename: PGPM-17-133-g0005.jpg
figure_link: /pmc/articles/PMC11033211/figure/f0005/
number: Figure 5
figure_title: ''
caption: 'Enrichment plots from the Gene Set Enrichment Analysis (GSEA). NAT1 were
  significantly enriched several pathways including: (A) Neuroactive ligand-receptor
  Interaction, (B) Olfactory transduction, (C) Olfactory signaling pathway, (D) ECM
  receptor interaction, (E) Base excision repair, (F) D4GDI pathway, (G) MHC pathway,
  (H) CTL pathway, and (I) IL17 pathway.'
article_title: Downregulation of NAT1 Expression is Associated with Poor Prognosis
  and Immune Infiltration in COAD.
citation: Houxi Xu, et al. Pharmgenomics Pers Med. 2024;17:133-148.
year: '2024'

doi: 10.2147/PGPM.S455490
journal_title: Pharmacogenomics and Personalized Medicine
journal_nlm_ta: Pharmgenomics Pers Med
publisher_name: Dove

keywords:
- NAT1
- COAD
- prognosis
- immune infiltration
- RT-qPCR
- western blot

---
